Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2

Review Article

Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 2

Details of adverse drug reactions (ADRs)/ adverse drug events (ADEs).

Experimental groupControl groupNo grouping

TRQ+WM vs. WM20 cases:
Fever, 8 cases; pruritus, 3 cases; nausea, 2 cases; vomiting, 2 cases; nausea and vomiting, 2 cases, popular rash, 2 cases; diarrhea, 1 case
23 cases:
Nausea and vomiting, 9 cases; dizziness, 4 cases; diarrhea, 4 cases; vomiting, 3 cases; nausea, 2 cases; chest pain, 1 case
10 cases:
Pain due to fluid dropping too fast, 3 cases; nausea, 4 cases; dizziness, 1 case; headache, 1 case; loss of appetite, 1 case
XBJ+WM vs. WM6 cases:
Vasculitis, 3 cases; skin rash, 1 case; pruritus, 1 case; flushing, 1 case
0/
DH+WM vs. WM4 cases:
Dizziness and flushing, 2 cases; elevated ALT, 2 cases
4 cases:
Elevated ALT, 4 cases
/
SM+WM vs. WM8 cases:
Stimulation in oropharynx, 3 cases; palpitation, 2 cases; nystagmus, 2 cases; skin rash, 1 case
5 cases:
Palpitation, 2 cases; nystagmus, 1 case; stimulation in oropharynx, 1 case; skin rash, 1 case
Mild headache, pruritus, skin rash and gastrointestinal adverse reactions
RDN+WM vs. WM7 cases:
Gastrointestinal adverse reactions, 3 cases; skin rash, 2 cases; dizziness, chest congestion and dry mouth, 2 cases
11 cases:
Gastrointestinal adverse reactions, 6 cases; skin rash, 5 cases
/
CXQ+WM vs. WM1 case:
Minor allergy, 1 case
0/
XYP+WM vs. WM1 case:
Diarrhea, 1 case
0/
SF+WM vs. WM1 case:
Pruritus, 1 case
0/
XXN+WM vs. WM13 cases:
Abdominal distension and nausea, 8 cases; dry mouth, 5 cases
0/
SMI+WM vs. WM5 cases:
Gastrointestinal adverse reactions, 1 case; non-specific adverse reactions, 4 cases
5 cases:
Gastrointestinal adverse reactions, 2 cases; non-specific adverse reactions, 3 cases
/
TRQ+WM vs. XYP+WM02 cases:
Phlebitis, 2 cases
/

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.